MC2 Therapeutics A/S: Financial statements 2013
CVR: 29526346
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 3,532,206 and a net result of DKK -25,006,950 compared with DKK -31,328,487 the year before. That is a decrease of 32.7% compared with the year before. Equity in the 2013 report amounted to DKK 15,928,139. The solvency ratio was 92.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,532,206
- Profit/Loss
- DKK -25,006,950
- Equity
- DKK 15,928,139
- Total Assets
- DKK 17,204,631
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 3.5 mio. | -25 mio. | 15.9 mio. | 3 |
| 2012 | - | 5.2 mio. | -31.3 mio. | -288.9 mio. | 4 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MC2 Therapeutics A/S has published its annual report for 2012. Gross profit came to DKK 5,245,429, and the net result was DKK -31,328,487.
About MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.